Biolife Solutions Inc
BLFS
Market Cap$1.2B
Close$
$-0.35
101.5% downside
Current Fair Value
101.5% downsideOvervalued by 101.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.20 Billion |
|---|---|
| Enterprise Value | $1.14 Billion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-0.44 |
| Beta | 1.93 |
| Outstanding Shares | 46,648,902 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -58.4 |
|---|---|
| PEG | 62.03 |
| Price to Sales | 11.65 |
| Price to Book Ratio | 3.33 |
| Enterprise Value to Revenue | 9.24 |
| Enterprise Value to EBIT | -40.76 |
| Enterprise Value to Net Income | -31 |
| Total Debt to Enterprise | 0.03 |
| Debt to Equity | 0.1 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Biolife Solutions Inc
CEO: Michael Rice